Commons Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Commons Capital's BMY Position: Q2 2026 in Review
Commons Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.04% in Q2 2026, selling an estimated $172 and leaving 7,414 shares worth $427K. The position accounts for 0.3% of the portfolio, ranked #59.
Commons Capital first reported a position in BMY in Q4 2021 and has held it in 15 quarters since. The position peaked at $523K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Commons Capital held 7,414 shares of Bristol-Myers Squibb worth $427K as of Q2 2026.
- Commons Capital sold 3 Bristol-Myers Squibb shares in Q2 2026, an estimated $172.
- Bristol-Myers Squibb made up 0.3% of Commons Capital's portfolio in Q2 2026, its #59 holding.
- Commons Capital first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 15 quarters since.
- Commons Capital's Bristol-Myers Squibb position peaked at $523K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Commons Capital's 13F filing for Q2 2026, filed 30 Jul 2026.